During insulin-resistance states such as T2D, the control of hepatic glucose production by insulin is defective yet the lipid promoting effects of insulin are maintained, leading to hyperglycemia and hypertriglyceridemia [47]. The gene discussed is INS; the disease is hypertriglyceridemia.